Preserved and reduced ejection fraction manifest as two mechanistically unique phenotypes of diastolic dysfunction

This study demonstrates that heart failure with preserved and reduced ejection fraction represent two distinct mechanistic phenotypes of diastolic dysfunction, characterized by increased damping in the former and reduced damping in the latter, despite similar conventional echocardiographic measures.

The Gist

The Big Idea: Two Different "Broken" Hearts

Imagine the heart is a balloon that needs to squeeze out blood and then relax to fill back up. This "filling up" phase is called diastole.

For a long time, doctors thought that when the heart had trouble filling up (diastolic dysfunction), it was usually because the heart muscle had become too stiff, like a balloon that had been over-inflated and lost its stretchiness. They assumed this was the main problem for two types of heart failure:

1. HFpEF (Preserved Ejection Fraction): The heart squeezes hard, but fills poorly.
2. HFrEF (Reduced Ejection Fraction): The heart squeezes weakly and fills poorly.

This study says: "Wait a minute."

The researchers used a special mathematical tool (called the PDF method) to look at the mechanics of how the heart fills. They discovered that while both groups have "bad filling," the reasons are completely different. In fact, they are almost opposites.

---

The Analogy: The Door and the Spring

To understand the findings, imagine a door that closes itself using a spring (like a screen door).

1. The Spring (Stiffness): This is the force that pulls the door shut. A stiffer spring pulls harder.
2. The Damper (Damping): This is the hydraulic piston on the door (the thing that stops the door from slamming). It creates resistance to slow the door down.

The researchers found that the two types of heart failure are broken in different parts of this door mechanism.

1. The "Sticky Door" (Heart Failure with Preserved EF)

• What happens: The door moves, but it feels like it's dragging through thick mud. It's not that the spring is too tight; it's that the damper is too strong.
• The Science: In patients with Preserved EF, the heart muscle has high damping. This means the tissue is "viscous" or sticky. It resists movement and loses energy as heat.
• The Result: The heart has to work much harder to push blood in because it's fighting against this internal friction. It's like trying to open a door that is stuck in honey.
• Key Takeaway: The problem isn't that the heart is "hard" (stiff); it's that it's "sticky" (high damping).

2. The "Loose Spring" (Heart Failure with Reduced EF)

• What happens: The door swings open too easily and doesn't have enough energy to close properly. The damper is too weak.
• The Science: In patients with Reduced EF, the heart muscle has low damping. Because the heart muscle is damaged and weak, it doesn't generate enough force to create that "viscous" resistance.
• The Result: The heart fills up, but it lacks the internal "braking" mechanism that healthy hearts have. It's like a door with a broken damper that slams shut or doesn't seal right.
• Key Takeaway: The problem here is that the heart is too "slippery" or lacks the necessary resistance (low damping).

---

The Surprise: Stiffness Didn't Change!

The biggest shock in this study was about Stiffness.

• Old Belief: Doctors thought the heart muscle in these patients was "stiff" (like a rock).
• New Finding: The study found that the actual stiffness of the heart muscle was the same in healthy people, "Sticky Door" patients, and "Loose Spring" patients.

Why does this matter?
It means we have been looking at the wrong part of the equation. We thought the heart was too hard to stretch, but actually, the heart is just as stretchy as a normal heart. The problem is how the heart moves through that stretch (the damping).

Why Should We Care?

Think of it like fixing a car.

• If you try to fix a car with a stuck transmission (High Damping) by replacing the engine (treating stiffness), it won't work. You need to fix the transmission fluid.
• If you try to fix a car with a wobbly suspension (Low Damping) by tightening the bolts (treating stiffness), it won't work. You need to add shock absorbers.

The Conclusion:
Because these two types of heart failure are broken in opposite ways, they need different treatments.

• Patients with Preserved EF might need drugs that reduce that "stickiness" (lower the damping).
• Patients with Reduced EF might need strategies to help them generate more force.

This study suggests that by understanding the "mechanics" of the heart (how it moves, not just how hard it is), we can finally start treating these patients with the right tools, rather than using a "one-size-fits-all" approach that hasn't been working very well.

Technical Summary

1. Problem Statement

Diastolic dysfunction is a prevalent and prognostically significant feature in both Heart Failure with Preserved Ejection Fraction (HFpEF) and Heart Failure with Reduced Ejection Fraction (HFrEF). Currently, these conditions are often categorized using conventional echocardiographic guidelines (e.g., 2016/2025 ASE guidelines) which rely on metrics like E/e', left atrial volume index (LAVI), and transmitral inflow patterns.

However, despite similar grading of diastolic dysfunction severity, patients with HFpEF and HFrEF exhibit vastly different responses to therapy. The authors posit that current classification systems fail to capture the underlying mechanistic differences in ventricular filling between these two phenotypes. Specifically, the traditional assumption that diastolic dysfunction is primarily driven by increased myocardial "stiffness" may be an oversimplification that overlooks other critical physical properties, such as damping (viscoelastic energy loss).

2. Methodology

Study Design:

• Type: Single-center, retrospective study.
• Population: 225 patients aged >50 years referred for cardiac assessment between 2018 and 2023.
• Groups:
  1. Controls (n=75): Normal systolic and diastolic function.
  2. pEF Group (n=75): Diastolic dysfunction (Grade 2 or 3) with preserved EF (>55%).
  3. rEF Group (n=75): Diastolic dysfunction (Grade 2 or 3) with reduced EF (<40%).
• Exclusion Criteria: Moderate-severe valvular disease, hypertrophic cardiomyopathy, prior cardiac surgery (CABG, valve replacement), or insufficient Doppler signals.

Analytical Approach:

• Conventional Echo: Assessed standard metrics (E/e', TR velocity, LAVI, E/A ratio) per ASE guidelines.
• Parameterised Diastolic Filling (PDF) Analysis: The core innovation of the study.
  • Mechanism: Models early diastolic filling (E-wave) as a damped harmonic oscillator (a spring-damper system).
  • Data Source: Pulsed-wave (PW) Doppler of the mitral inflow.
  • Key Parameters Derived:
    • Stiffness ($k$): Resistance to deformation (restorative force).
    • Damping ($c$): Viscoelastic energy loss opposing filling (analogous to a dashpot).
    • Load ($x_0$): Deforming volume/preload.
    • Secondary Metrics: Kinematic Filling Efficiency Index (KFEI), estimated time constant of relaxation ($\tau$), peak driving/resistive forces.
  • Tool: Web-based application (Echo E-waves) used for curve-fitting the E-wave velocity profile.

Statistical Analysis:

• Comparison of continuous variables using One-way ANOVA or Kruskal-Wallis tests.
• Data reported as mean $\pm$ SD or median [IQR].

3. Key Contributions

• Mechanistic Differentiation: The study provides the first quantitative evidence that HFpEF and HFrEF represent fundamentally distinct mechanistic phenotypes of diastolic dysfunction, despite appearing similar on standard echocardiograms.
• Reframing "Stiffness": It challenges the dogma that diastolic dysfunction is solely a problem of increased chamber stiffness. The study demonstrates that stiffness may remain unchanged while other parameters drive the pathology.
• Identification of Damping as a Primary Driver: The paper highlights damping (viscoelastic energy dissipation) as the critical differentiator between the two groups, a parameter often overlooked in clinical practice due to a lack of quantification methods.
• Clinical Implications: These findings suggest that therapies targeting myocardial stiffness may not be universally effective and that targeting damping mechanisms could be a novel therapeutic avenue, particularly for HFpEF.

4. Key Results

Conventional Echocardiography:

• pEF and rEF groups showed no significant differences in E/e', TR peak velocity, or LAVI ($p > 0.05$).
• Differences were noted in E-wave velocity (higher in pEF) and E/A ratio (lower in pEF), consistent with their respective grading.

PDF Mechanistic Parameters:

• Stiffness: No significant difference was found between Controls, pEF, and rEF groups ($p > 0.3$). This contradicts the common assumption that HFpEF is defined by a "stiffer" ventricle in the context of early filling mechanics.
• Damping:
  • pEF: Significantly increased compared to controls ($24.1$ vs $19.8$g/s;$p < 0.001$).
  • rEF: Significantly decreased compared to controls ($16.1$ vs $19.8$g/s;$p = 0.005$).
• Load:
  • pEF: Significantly increased compared to controls ($13.7$ vs $9.7$ cm; $p < 0.001$).
  • rEF: No significant difference from controls.
• Kinematic Filling Efficiency Index (KFEI):
  • pEF: Decreased (worse efficiency), indicating greater energy loss.
  • rEF: Increased (better efficiency relative to load/stiffness).
• Relaxation Time ($\tau$): Increased in pEF (slower relaxation) but decreased in rEF.

5. Significance and Discussion

• Pathophysiological Insight:
  • HFpEF (pEF): Characterized by increased damping and increased load. The authors suggest this may be driven by diffuse myocardial fibrosis, disruption of myofiber organization, or impaired calcium sequestration, leading to high energy dissipation (viscosity) during filling. The increased load suggests higher filling pressures are required to overcome this resistance.
  • HFrEF (rEF): Characterized by decreased damping. This may result from reduced systolic contraction generating less stored elastic energy, or focal replacement fibrosis (scarring) altering the viscoelastic properties differently than diffuse fibrosis.
• Therapeutic Implications:
  • Since HFpEF and HFrEF have opposite mechanical profiles regarding damping, a "one-size-fits-all" approach to diastolic dysfunction is flawed.
  • Therapies for HFpEF might need to focus on reducing myocardial viscosity or improving relaxation efficiency rather than just reducing stiffness.
• Limitations:
  • PDF analysis is sensitive to measurement errors in E-wave acceleration/deceleration times.
  • The method does not account for atrial contribution (late diastole).
  • Loading conditions (preload/afterload) can influence PDF parameters, though the study controlled for this via group comparisons.
  • The cohort is heterogeneous regarding specific etiologies of heart failure.

Conclusion:
The study concludes that diastolic dysfunction in preserved and reduced ejection fraction is not a single entity but two unique physiologic conditions. The primary distinction lies in damping (increased in HFpEF, decreased in HFrEF) rather than stiffness. This paradigm shift offers a new framework for understanding heart failure pathophysiology and developing targeted treatments.